Day: March 26, 2026

us corporate news

Aspira Women’s Health Inc. Announces Mayo Clinic Laboratories Agreement for Ova1Plus and OvaWatch Tests – SEC 8-K Filing December 2025

Minichart

March 26, 2026

Aspira Women’s Health Inc. Enters Material Agreement with Ma...

Continue Reading 0

us corporate news

Recursion Pharmaceuticals Appoints Vicki Goodman, M.D. as Chief Medical Officer to Advance Clinical Pipeline and AI-Driven Drug Development 1

Minichart

March 26, 2026

Recursion Pharmaceuticals Announces New Chief Medical Office...

Continue Reading 0

us corporate news

SelectQuote Receives NYSE Non-Compliance Notice, Outlines Plan to Regain Listing and Highlights Strong Financial Position

Minichart

March 26, 2026

SelectQuote Receives NYSE Non-Compliance Notice, Outlines St...

Continue Reading 0

us corporate news

CID HoldCo, Inc. Files Form 8-K Disclosing Director Resignation and Company Information (March 2026)

Minichart

March 26, 2026

CID Holdco, Inc. 8-K Filing: Key Investor Update CID Hol...

Continue Reading 0

us corporate news

Apogee Therapeutics Announces $350 Million Public Offering of 5 Million Shares in Underwriting Agreement with Jefferies, TD Securities, Stifel, and Guggenheim 12137980

Minichart

March 26, 2026

Apogee Therapeutics, Inc. Announces \$350 Million Public Off...

Continue Reading 0

us corporate news

CIMG Inc. Reports Q1 2025 Revenue Surge and Strategic Expansion in Digital Health, Computing Power, and Bitcoin Holdings

Minichart

March 26, 2026

CIMG Inc. Q1 Financial Results: Major Revenue Surge, Digital...

Continue Reading 0

us corporate news

Lindblad Expeditions Holdings, Inc. Files Form 8-K Report with SEC – Company Details and Key Entity Information (March 19, 2026) 21

Minichart

March 26, 2026

Lindblad Expeditions Holdings, Inc. – Investor Update (Form ...

Continue Reading 0

us corporate news

Saba Capital Income & Opportunities Fund II Files Form 8-K with SEC – Company Details, Address, and Key Information

Minichart

March 26, 2026

Saba Capital Income & Opportunities Fund II - Detailed Inves...

Continue Reading 0

us corporate news

Precigen Achieves First Commercial Revenue in 2025 with FDA Approval and Strong US Launch of PAPZIMEOS for RRP

Minichart

March 26, 2026

Precigen 2025 Full Year Financial Results & Business Update:...

Continue Reading 0

us corporate news

Nuvve Holding Corp. 8-K Filing March 2026 – Amended Employment Agreement with CFO David Robson

Minichart

March 26, 2026

Nuvve Holding Corp. (NASDAQ: NVVE) Announces Expiry and Deli...

Continue Reading 0